EnteraSense’s product, which is single-use and prescription-only, is engineered to detect blood in patients “suspected of having upper gastrointestinal bleeding,” the FDA said Feb. 24. It is not a standalone treatment but is intended to be used among other clinical decision-making devices.
The Pill Sense System consists of a reusable receiver and a single-use ingestible capsule that resembles a clear battery.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
